Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-27
2008-09-30
Fay, Zohreh A (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S322000, C514S912000
Reexamination Certificate
active
07429602
ABSTRACT:
Treating allergic conjunctivitis by administered aqueous solutions containing epinastine, optionally in the form of its racemate or its enantiomers and optionally, in the form of the pharmacologically acceptable acid addition salts thereof, to the conjunctiva.
REFERENCES:
patent: 4313931 (1982-02-01), Walther et al.
patent: 5668133 (1997-09-01), Yanni et al.
patent: 5942503 (1999-08-01), Jung et al.
patent: 6649602 (2003-11-01), Yanni
patent: 2002/0037297 (2002-03-01), Crespo
patent: 2003/0050303 (2003-03-01), Trach
patent: 2005/0288274 (2005-12-01), Trach
patent: 2007/0185082 (2007-08-01), Trach
patent: 2007/0197503 (2007-08-01), Trach
Duschler Gerold
Trach Volker
Boehringer Ingelheim Pharma GmbH & Co. Kg
Devlin Mary-Ellen M.
Fay Zohreh A
Morris Michael P.
Witkowski Timothy X.
LandOfFree
Treating conjunctivitis by topically administering an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating conjunctivitis by topically administering an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating conjunctivitis by topically administering an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3989504